InStride Health
About InStride Health
Co-founded by the clinicians who co-developed the McLean Anxiety Mastery Program (MAMP) at McLean Hospital, the nationally recognized program for children and adolescents with moderate to severe anxiety and OCD, InStride Health is leading the way to provide desperately needed access to more effective treatment of severe anxiety and OCD. Driven by the belief that children and families living with mental health struggles deserve better access and outcomes, InStride is more than a continuum of care—it’s a pathway to a healthier life and hope for a more promising future.
Hopelab has been an invaluable partner in the design and roadmap development of the InStride patient and caregiver applications. Hopelab conducted extensive discovery sessions with our team and patients to best understand how a mobile application can be used to supplement and enhance our care model. Through Hopleab’s partnership, the InStride app is available 24-7 to help our patients and caregivers, providing them with digital support they need during their treatment.
Why We Invested
Through this innovative care model, InStride is leading the way to provide desperately needed access to more effective treatment of anxiety and OCD. Driven by the belief that children and families living with mental health struggles deserve better access and outcomes so they never have to worry alone, InStride is more than a continuum of care—it’s a pathway to a healthier life and hope for a more promising future.
Collaborations with InStride Health
Hopelab’s Investment in InStride Health
In partnership with InStride HealthInStride raises $30 million in Series B funding to support increased access to specialty outpatient care for pediatric anxiety and OCD
